On 7th November 2011 the High Court in London found in favor of Porton Group, with 3M being forced to pay damages for breach of its contractual obligations over their failure to accurately test, actively market and successfully seek regulatory approval in the US.
On 7th November 2011 the High Court in London found 3M was "in material breach of its obligation" actively market the product, BacLite. The High Court Judge, Mr Justice Hamblen, awarded damages against 3M for breach of its contractual obligations over their failure to accurately test, actively market and successfully seek FDA regulatory approval in the US.